BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 26604731)

  • 41. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
    Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Wang Y; Fei J; Xu J; Cheng ZY; Ma YC; Wu JH; Yang J; Zhao H; Fu L
    Lung; 2024 Jun; 202(3):245-255. PubMed ID: 38743087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.
    Husebø GR; Bakke PS; Aanerud M; Hardie JA; Ueland T; Grønseth R; Persson LJ; Aukrust P; Eagan TM
    PLoS One; 2014; 9(10):e109721. PubMed ID: 25279458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
    Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
    Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.
    Powrie DJ; Wilkinson TM; Donaldson GC; Jones P; Scrine K; Viel K; Kesten S; Wedzicha JA
    Eur Respir J; 2007 Sep; 30(3):472-8. PubMed ID: 17504798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study.
    Chang C; Zhu H; Shen N; Chen Y; He B; Zhao J; Yao W
    COPD; 2015 Feb; 12(1):19-30. PubMed ID: 24800883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The recent advances of phenotypes in acute exacerbations of COPD.
    Zhou A; Zhou Z; Zhao Y; Chen P
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1009-1018. PubMed ID: 28392685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.
    Bartels W; Adamson S; Leung L; Sin DD; van Eeden SF
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1647-1654. PubMed ID: 29872284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease.
    Ruiz-González A; Lacasta D; Ibarz M; Martínez-Alonso M; Falguera M; Porcel JM
    Respirology; 2008 Nov; 13(7):1028-33. PubMed ID: 18945322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD.
    Nair S; Thomas E; Pearson SB; Henry MT
    Chest; 2005 Jul; 128(1):48-54. PubMed ID: 16002915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
    Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
    Trials; 2012 Apr; 13():40. PubMed ID: 22520863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
    Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
    Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
    Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
    Ra SW; Sze MA; Lee EC; Tam S; Oh Y; Fishbane N; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Sin DD;
    Respir Res; 2017 May; 18(1):109. PubMed ID: 28558695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
    Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
    Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
    Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
    Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.